This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 4 CIPO patents and 1 EPO patent. Top assignees: Shanghai Meiyue Biotech Development Co., Ltd., Wuhan Createrna Science and Technology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Chaodong Wang: Innovator in Pharmaceutical Chemistry
Introduction
Chaodong Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical use. His work focuses on the preparation and application of IRAK inhibitors, which have potential therapeutic benefits.
Latest Patents
Chaodong Wang holds a patent for an IRAK inhibitor and its preparation method. The patent describes a compound represented by a specific formula, which includes various forms such as stereoisomers, racemates, tautomers, isotopic labels, prodrugs, and pharmaceutically acceptable salts. Additionally, the patent outlines a pharmaceutical composition containing the compound, along with its preparation method and medical applications.
Career Highlights
Chaodong Wang is associated with Wuhan Createrna Science and Technology Co., Ltd., where he continues to advance his research and development efforts. His innovative work has led to the creation of valuable compounds that may contribute to new therapeutic strategies.
Collaborations
Chaodong Wang collaborates with notable colleagues in his field, including Guozhong Ye and Chenli Ding. These partnerships enhance the research and development process, fostering innovation and the sharing of expertise.
Conclusion
Chaodong Wang is a key figure in the realm of pharmaceutical innovation, with a focus on IRAK inhibitors. His contributions to the field are marked by his patent and ongoing research efforts. His work exemplifies the importance of innovation in developing new medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile